Guangzhou LBP Medicine Science & Technology Co., Ltd. (LBP SYSTEM) was founded in 2005, is China's first publicly listed company in the pathological diagnosis field(Stock Code: 688393). Focused on products and services for tumor screening and precision diagnosis, it integrates R&D, production, marketing, service, and education into one comprehensive framework, serving over 2,400 medical institutions. As a high-tech enterprise, it boasts one of the most complete pathological product lines, diverse product categories, and multifaceted business operations in the industry.
LBP SYSTEM has established the "Four Modernizations" — automation, standardization, digitization, and intelligence — as its strategic direction for pathology departments. It has completed a full industrial chain development layout spanning biological raw materials, pathology department products, digital-intelligent technology software, and pathological capability enhancement services. The company has independently developed supporting equipment and reagent consumables across technology platforms including Liquid-Based Cytology (LBC), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and Digital Pathology & Artificial Intelligence (DP&AI). Driven by a "products + services" dual-drive model, it has expanded into service businesses such as smart pathology department construction, pathological capability upgrading, and companion diagnostics for pharmaceutical companies, actively promoting high-quality development in the pathology industry.
Currently, LBP SYSTEM operates three major R&D centers in Guangzhou, Shanghai, and Suzhou. In 2024, it established a Singapore branch (SingPath) to fully expand into global markets. Multiple products have obtained CE European certification, as well as quality certifications from the British Standards Institution (BSI) and Japan's Ministry of Health, Labour and Welfare. Committed to benefiting society through precision medical diagnostics, LBP SYSTEM strives to become a global leader in the pathological diagnosis field.
